Cat. No. |
Product Name / Activity |
6602 |
1M7 |
| Reagent for RNA SHAPE-MaP chemistry |
7376 |
2A3 |
| Reagent for RNA SHAPE-MaP experiments in vivo; cell permeable |
5962 |
3-AP |
| Ribonucleotide reductase inhibitor; also an iron chelator |
3771 |
Azithromycin |
| Antibiotic; inhibits 50S ribosomal subunit formation and elongation at transpeptidation |
3681 |
Bendamustine hydrochloride |
| Cytostatic agent; exhibits DNA alkylating and purine analog properties |
5015 |
5-BrdU |
| Synthetic thymidine analog; used for cell proliferation assays |
8108 |
CEP |
| Chemoproteomic reagent, clickable electrophilic purine for RNA binding profiling in live cells |
4091 |
Cyclophosphamide |
| Alkylating agent; chemotherapeutic |
7207 |
5-Ethynyl-2'-deoxyuridine |
| Thymidine analog for labeling DNA; can be linked to a fluorophore by click chemistry |
7206 |
5-Ethynyluridine |
| Uridine analog, used for labeling RNA synthesis |
8011 |
FAI |
| Reagent for RNA SHAPE-MaP experiments in live cells |
5075 |
Harmine |
| Binds to the yjdF aptamer; activates riboswitch function; also DYRK1A inhibitor |
6782 |
Indisulam |
| Pre-mRNA splicing modulator; hCA XII inhibitor |
5284 |
trans-ISRIB |
| Integrated stress response (ISR) inhibitor |
5185 |
JTE 607 dihydrochloride |
| Active metabolite binds CPSF3; Pro-drug |
7586 |
Molnupiravir |
| Prodrug of antiviral nucleoside analog; inhibits SARS-CoV, SARS-CoV-2 and MERS-CoV infection |
7004 |
NAI |
| Reagent for RNA SHAPE-MaP experiments in vivo; cell permeable |
7974 |
P3S |
| Reagent for modifying RNA at 2'-OH position, for SHAPE-MAP experiments |
6862 |
Psoralen-triethylene glycol azide |
| RNA conformation probe; reagent for COMRADES RNA platform |
7916 |
Risdiplam |
| Selective SMN2 gene splicing modifier |
6586 |
Targapremir 210 |
| Inhibits formation of miR-210 |
7788 |
TBIA |
| Bivalent SHAPE cross-linking reagent |
4562 |
Topotecan hydrochloride |
| Binds to U4 RNA and inhibits RNA splicing; also DNA topoisomerase I inhibitor |